Bausch Health Companies Inc. Q2 FY2021 Earnings Call

Bausch Health Companies Inc. (BHC)

Earnings Call FY2021 Q2 Call date: 2021-08-03 Concluded

Quarter scorecard

Revenue

$2.10B

+26.2% YoY

Diluted EPS

$-1.66

Net income

-$595.00M

Pharmaceutical Products $942.00M

+20%

Device Products $470.00M

+79.4%

Over the Counter Products $359.00M

+13.2%

Branded and Other Generic Products $305.00M

+11.7%

Product And Service Other $24.00M

-11.1%